Correction: miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma

Oncotarget. 2018 Feb 23;9(15):12534. doi: 10.18632/oncotarget.24557.

¹ Department of Experimental Oncology and Molecular Medicine, Molecular Mechanisms Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
² Department of Experimental Oncology and Molecular Medicine, Functional Genomics Core Facility, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
³ Laboratory of Pre-Clinical and Translational Research, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture (PZ), Italy.
⁴ Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
⁵ Department of Diagnostic Imaging and Radiotherapy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
⁶ Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
⁷ Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.7262.].